Paradigm Financial Partners, LLC Enzo Biochem Inc Transaction History
Paradigm Financial Partners, LLC
- $778 Million
- Q4 2024
A detailed history of Paradigm Financial Partners, LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 19,500 shares of ENZ stock, worth $10,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,500
Previous 19,500
-0.0%
Holding current value
$10,725
Previous $21,000
38.1%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ENZ
# of Institutions
49Shares Held
15.7MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.85 Million1.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.37MShares$1.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$1.02 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...